Guidant Gains FDA Approval Of MADIT II Indication, Reports Upbeat ICD Sales
This article was originally published in The Gray Sheet
Executive Summary
Patient electrophysiology testing "may not be required" for some patients prior to Guidant ICD implantation under an expanded indication, FDA says